Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice
Hamid Mahmoudzadeh-Niknam, Simin Sadat Kiaei, Davood Iravani
Korean J Parasito. 2007;45(2):103-109.   Published online 2007 Jun 20     DOI: https://doi.org/10.3347/kjp.2007.45.2.103
Citations to this article as recorded by Crossref logo
Interspecies and Intrastrain Interplay among Leishmania spp. Parasites
Bruna Dias das Chagas, Thaís Martins Pereira, Lilian Motta Cantanhêde, Gabriela Pereira da Silva, Mariana Côrtes Boité, Luiza de Oliveira Ramos Pereira, Elisa Cupolillo
Microorganisms.2022; 10(10): 1883.     CrossRef
Integration of Bioinformatics and in vitro Analysis Reveal Anti-leishmanial Effects of Azithromycin and Nystatin
Irum Jehangir, Syed Farhan Ahmad, Maryam Jehangir, Anwar Jamal, Momin Khan
Current Bioinformatics.2019; 14(5): 450.     CrossRef
Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice
Mosayeb Rostamian, Fariborz Bahrami, Hamid M. Niknam, Humberto Lanz-Mendoza
PLOS ONE.2018; 13(9): e0204491.     CrossRef
Route of Infection Affects Pathogenicity of Leishmania major in BALB/c Mice
Ehsan Sarreshteh, Mosayeb Rostamian, Mahsa Tat Asadi, Firoozeh Abrishami, Ali Najafi, Maryam Abolghazi, Hamid Mahmoudzadeh Niknam
Journal of Medical Microbiology and Infectious Diseases .2017; 5(1): 26.     CrossRef
Studies on cocktails of 31‐kDa, 36‐kDa and 51‐kDa antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis
H. Kaur, A. Thakur, S. Kaur
Parasite Immunology.2015; 37(4): 192.     CrossRef
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis
Emily Rose Mears, Farrokh Modabber, Robert Don, George E. Johnson, Louis Maes
PLOS Neglected Tropical Diseases.2015; 9(9): e0003889.     CrossRef
Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice
JYOTI JOSHI, SUKHBIR KAUR
Parasitology.2014; 141(4): 554.     CrossRef
The Route of Leishmania tropica Infection Determines Disease Outcome and Protection against Leishmania major in BALB/c Mice
Hamid Mahmoudzadeh-Niknam, Ghader Khalili, Firoozeh Abrishami, Ali Najafy, Vahid Khaze
The Korean Journal of Parasitology.2013; 51(1): 69.     CrossRef
Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis
Tejinder Kaur, Prerna Makkar, Kulbir Randhawa, Sukhbir Kaur
Parasitology Research.2013; 112(1): 91.     CrossRef
Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice
Hamid Mahmoudzadeh-Niknam, Simin Sadat Kiaei, Davood Iravani
Experimental Parasitology.2011; 127(2): 448.     CrossRef
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
Clarisa B Palatnik-de-Sousa, André de Figueiredo Barbosa, Sandra Maria Oliveira, Dirlei Nico, Robson Ronney Bernardo, Wania R Santos, Mauricio M Rodrigues, Irene Soares, Gulnara P Borja-Cabrera
Expert Review of Vaccines.2008; 7(6): 833.     CrossRef
Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis
Hamid Mahmoudzadeh-Niknam, Simin Sadat Kiaei, Davood Iravani
The Korean Journal of Parasitology.2007; 45(4): 247.     CrossRef